All these data support our observations that in luminal A breast cancer cells, NOTCH3 can act as an oncogenic protein when it is phosphorylated at serine 1672, whereas the nonphosphorylated form of N3ICD remains tumor-suppressive. This evidence concerns the gene NOTCH3 and breast carcinoma.